Pathology Oncology Research

, Volume 9, Issue 3, pp 193–195 | Cite as

Renal medullary carcinoma in a six-year-old boy with sickle cell trait

  • Roberto Vargas-Gonzalez
  • Cirilo Sotelo-Avila
  • Araceli Solis Coria
Case Report


Renal medullary carcinoma (RMC), an aggressive malignant epithelial neoplasm, first emerged as a distinct clinicopathologic entity in 1995. It affects individuals 40 years of age or younger and is strongly associated with sickle cell disease or trait. The majority of patients with RMC have widely disseminated disease at the time of diagnosis and most fail to respond to both chemotherapy and radiotherapy. Mortality approaches 100%, and death usually occurs within a few months to a year of diagnosis. We report a 6-year-old African-American boy with a history of gross hematuria who died four weeks after diagnosis of disseminated metastatic disease. Autopsy showed a 4.4-cm renal mass with metastases to the contra lateral kidney, liver, lungs and multiregional lymph nodes. RMC should be included in the differential diagnosis of any patient 40 years old or younger with a history of hemoglo-binopathy and gross hematuria and/or abdominal or flank pain. A brief discussion of the differential diagnosis, histogenesis and treatment is presented in this study.


sickle cell disease renal medullary carcinoma collecting duct carcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berman LB: Sickle cell nephropathy. JAMA 228:1279, 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Davis CJJ, Mostofi FK, Sesterhenn IA: Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 19: 1–11, 1995.PubMedCrossRefGoogle Scholar
  3. 3.
    Avery RA, Harris JE, Davis CJJ, et al: Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 78: 128–132, 1996.PubMedCrossRefGoogle Scholar
  4. 4.
    Dimashkieh H, Choe J, Mutema G: Renal medullary carcinoma a report of two cases and review of the literature. Arch Pathol Lab Med 127:135–138, 2003.Google Scholar
  5. 5.
    Swartz MA, Karth J, Schneider DT et al. Renal medullary carcinoma: Clinical, pathologic, immunohistochemical and genetic analysis with pathogenic implications. Urology 60: 1083–89, 2002.PubMedCrossRefGoogle Scholar
  6. 6.
    Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 195: 83–85, 1995.PubMedGoogle Scholar
  7. 7.
    Srigley JR, Eble JN: Collecting duct carcinoma of kidney. Semin Diagn Pathol 15: 54–67, 1998.PubMedGoogle Scholar
  8. 8.
    Mostofi FK, Vorder Bruegge CF, Diggs LW: Lesions in kidneys removed for unilateral hematuria in sickle cell disease. Arch Pathol 63: 336–51, 1957.Google Scholar
  9. 9.
    Pham PT, Pham PC, Wilkinson AH, et al: Renal abnormalities in patients in sickle cell disease. Kidney Int 57: 1–8, 2000.PubMedCrossRefGoogle Scholar
  10. 10.
    Ataga KI, Orringer EP: Renal abnormalities in sickle cell disease. Am J Hematol 63: 205–211, 2000.PubMedCrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2003

Authors and Affiliations

  • Roberto Vargas-Gonzalez
    • 1
  • Cirilo Sotelo-Avila
    • 2
  • Araceli Solis Coria
    • 3
  1. 1.Department of PathologyHospital Para el Niño PoblanoPueblaMéxico
  2. 2.Department of PathologyCardinal Glennon Children’s HospitalSaint Louis MissouriUSA
  3. 3.Department of PediatricsHospital Infantil de México Federico GomezMéxico DFMéxico

Personalised recommendations